Cytomegalovirus infections (Q34743437)

4 August 2017

1 reference

title

Cytomegalovirus infections. (English)

1 reference

4 August 2017

0 references

Mohamad Khoshnevis

1

1 reference

PubMed ID

12120442

4 August 2017

Stephen K Tyring

series ordinal

2

1 reference

4 August 2017

1 April 2002

1 reference

4 August 2017

1 reference

4 August 2017

20

1 reference

4 August 2017

2

1 reference

4 August 2017

291-9, vii

1 reference

Summary of the II International Symposium on Cytomegalovirus.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus infection in normal and immunocompromised humans. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Hyperimmediate entry of human cytomegalovirus virions and dense bodies into human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

The pathogenicity of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus cell tropism and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Interaction of Cytomegalovirus with Leukocytes from Patients with Mononucleosis Due to Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus Infection of Human Blood Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus productively infects primary differentiated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

A novel mechanism for persistence of human cytomegalovirus in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

1 reference

7 January 2021

Treatment of cytomegalovirus diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus infection in the normal host

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Histologically specific skin lesions in disseminated cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalic inclusion disease of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Clinically occult cytomegalovirus present in skin biopsy specimens in immunosuppressed hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Vesiculobullous lesions caused by cytomegalovirus infection in an immunocompromised adult

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Papular-purpuric gloves-and-socks syndrome related to cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Diagnosis and treatment of a case of cutaneous cytomegalovirus infection with a dramatic clinical presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Preemptive Therapy in Immunocompromised Hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Oral infections due to cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Viral dynamics during active cytomegalovirus infection and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cytomegalovirus Infection in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2801%2900007-9

7 January 2021

10.1016/S0733-8635(01)00007-9

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12120442